DSGN Stock Discussion
Design Therapeutics, Inc. Description
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Popular Now
Featured Articles